v3.26.1
Income Tax (Tables)
 5 Months Ended 12 Months Ended
Dec. 31, 2025
Dec. 31, 2025
Jul. 31, 2025
Parent Company [Member]      
Schedule of Reconciliation of Income Tax Benefit

   December 31, 2025   %   December 31, 2024   % 
Income tax benefit at the federal statutory rate from continuing operations  $(47)   21.0   $(49)   21.0 
State income taxes, net of effect of federal taxes   (10)   4.3    (10)   4.3 
Expired net operating losses   0    -    0    - 
Change in valuation allowance   57    (25.3)   59    (25.3 
Total  $-    -   $-    - 
  

 

   July 31, 2025   %   July 31, 2024   % 
Income tax benefit at the federal statutory rate from continuing operations  $(47)   21.0   $(49)   21.0 
State income taxes, net of effect of federal taxes   (10)   4.3    (10)   4.3 
Expired net operating losses   0    -    0    - 
Change in valuation allowance   57    (25.3)   59    (25.3 
Total  $-    -   $-    - 
Schedule of Deferred Tax Assets For Federal Income Taxes

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets consist of the following (in thousands):

 

   December 31, 2025   July 31, 2025 
Federal and State net operating loss  $3,886   $3,886 
Foreign net operating loss   18    18 
Other   -    - 
Gross deferred tax assets   3,904    3,904 
Less: Valuation allowance   (3,904)   (3,904)
Net deferred tax asset  $-   $- 
  

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets consist of the following (in thousands):

 

   July 31, 2025   July 31, 2024 
Federal and State net operating loss  $3,886   $3,830 
Foreign net operating loss   18    18 
Other   -    - 
Gross deferred tax assets   3,904    3,848 
Less: Valuation allowance   (3,904)   (3,848)
Net deferred tax asset  $-   $- 
Gravitics Inc [Member]      
Schedule of Reconciliation of Income Tax Benefit  

A reconciliation of income tax benefit at the statutory federal income tax rate to income taxes as reflected in the financial statements is as follows:

Schedule of Reconciliation of Income Tax Benefit

                 
   Year Ended December 31, 
   2025   2024 
   $   %   $   % 
U.S. Statutory Tax Rate  $(2,457)   21.0%  $(1,900)   21.0%
Change in Valuation Allowances   1,594    -13.6%   1,075    -11.9%
Nontaxable or Nondeductible Items                    
Change in Fair Value of SAFE Notes   (243)   2.1%   233    -2.6%
Change in FV Convertible Notes   390    -3.3%   262    -2.9%
Change in FV of Warrants   417    -3.6%   18    -0.2%
Share-Based Compensation   278    -2.4%   310    -3.4%
Payroll Tax Credit   (63)   0.5%   -    0.0%
R&D 280(c) Addback   80    -0.7%   -    0.0%
Other   4    0.0%   2    0.0%
Actual income tax benefit effective tax rate  $-    0.0%  $-    0.0%

  
Schedule of Deferred Tax Assets For Federal Income Taxes  

Significant components of the Company’s deferred tax assets for federal income taxes consisted of the following:

         
   December 31, 
   2025   2024 
Deferred tax assets:          
Net operating loss carryforwards  $4,956   $2,980 
Capitalized research and development expenditures   1,146    1,580 
Lease liabilities   361    442 
Research and development tax credits   23    23 
Share-based compensation   14    6 
Accrued expenses and other   4    3 
Total deferred tax assets   6,504    5,034 
Less: valuation allowance   (6,081)   (4,487)
Deferred tax asset, net of valuation allowance  $423   $547 
Deferred tax liabilities:          
Fixed assets   (46)   (63)
Right-of-use assets   (377)   (484)
Total deferred tax liabilities   (423)   (547)
Net deferred tax assets  $-   $-